Method for removing cephalomannine from paclitaxel

A technology of cephalomannine and paclitaxel, which is applied in the field of separation and purification of paclitaxel, can solve the problems of expensive ozone generator equipment, relatively harsh conditions, and high production costs, and achieve mild reaction and treatment conditions, good removal effect, and high purity and the effect of high recovery rate

Inactive Publication Date: 2015-01-07
无锡紫杉药业股份有限公司
View PDF6 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But, also there is shortcoming in these two kinds of methods: when the crude extract is oxidized with ozone, many side reactions will be produced, and the ozonolysis reaction is very strong, and it is non-selective, and can remove paclitaxel and cephalomannine Undesirable oxidation reactions occur in many functional groups of many functional groups, such as reactions with ketones, alcohols, amines, etc. in the paclitaxel molecule, or reactions with the double bond on the taxane ring of paclitaxel and cephalomannine. In addition, the ozone generator equipment It is also very expensive, and the production cost is high; the method of halogen addition has strict requirements on the reaction conditions, which need to be around 0-5°C, protected from light, too long exposure to the reaction or excessive halogen will cause paclitaxel to degrade, and bromine as a low In the case of boiling point liquid halogen and high toxicity, there are higher requirements for production conditions

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for removing cephalomannine from paclitaxel
  • Method for removing cephalomannine from paclitaxel
  • Method for removing cephalomannine from paclitaxel

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] (1) Take 50 g of paclitaxel crude product (paclitaxel content 47.6wt%, cephalomannine content 10.1wt%) with 300ml acetone and add potassium permanganate solution (2.5g add 100ml acetone to dissolve) to react. After reacting for 3 hours, filter to obtain about 450ml of filtrate, add 250ml of purified water to crystallize, and dry the crystals to obtain 31.3g. According to HPLC detection, the content of paclitaxel is 74.2%, the content of cephalomannine is 0.44%, and the yield of paclitaxel is 97.6%.

[0041] (2) Dissolve the product from the previous step with dichloromethane to obtain a wet sample, add 360g of silica gel to a 50×500 glass column, and moisten the column with dichloromethane, then add the wet sample to the head of the column, and use the volume of ethyl acetate The mixed solvent of ethyl acetate and dichloromethane with a percentage of 30% was used as the mobile phase for elution, and the main segment was collected, a total of 1.5L. After concentration and...

Embodiment 2

[0043] (1) get paclitaxel crude product 300g (paclitaxel content 52.8wt%, cephalomannine content 16.1wt%, the liquid chromatogram of its efficient separation preparation is as follows image 3 Shown, the peak at 48.6 place is the characteristic peak of paclitaxel, the peak at 42.4 place is the characteristic peak of cephalomannine) add potassium permanganate solution (7g adds 900ml acetone to dissolve) after dissolving with 3000ml acetone and react. After reacting for 8 hours, filter to obtain about 4000ml of filtrate, add 7000ml of purified water to crystallize, and dry the crystals to obtain 203.2g. HPLC detection, the detection results are as follows: Figure 4 Shown, the peak at 48.1 place is the characteristic peak of paclitaxel, and the peak at 42.1 place is the characteristic peak of cephalomannine, and after analysis, obtaining the paclitaxel content is 76.7%, and the cephalomannine content is 0.58%, and the paclitaxel yield is 98.4%.

[0044] (2) Dissolve the product...

Embodiment 3

[0046] (1) 1000 g of paclitaxel crude product (paclitaxel content 50.1 wt%, cephalomannine content 19.8 wt %) was dissolved in 8 L of acetone, and potassium permanganate solution was added (60 g was dissolved in 2 L of acetone) for reaction. After reacting for 5 hours, filter to obtain about 10.5 L of filtrate, add 10 L of purified water to crystallize, and dry the crystals to obtain 690.3 g. According to HPLC detection, the content of paclitaxel is 71.2%, the content of cephalomannine is 0.67%, and the yield of paclitaxel is 98.1%.

[0047] (2) Dissolve the product from the previous step with dichloromethane to obtain a wet sample, add 45kg of silica gel to the 400×1000 stainless steel column, moisten the column with dichloromethane, then add the wet sample to the head of the column, and use the volume of ethyl acetate The mixed solvent of ethyl acetate and dichloromethane with a percentage of 20% was used as the mobile phase for elution, and the main segment was collected, wi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a method for removing cephalomannine from paclitaxel. The method comprises the following steps: 1) preparation of raw materials: dissolving a cephalomannine-containing paclitaxel crude product into an organic solvent to prepare a solution A, and dissolving potassium permanganate into an organic solvent to prepare a solution B; 2) reaction: reacting the solution A with the solution B, and filtering the solution obtained by reaction; 3) primary crystallization: crystallizing filtrate obtained in step 2); 4) column chromatography: filtering and drying the product obtained in step 3) for column chromatography, collecting paclitaxel-containing effective segments, and performing concentration and drying; 5) secondary crystallization: performing crystallization treatment on a drying product obtained in step 4) to obtain a paclitaxel pure product with paclitaxel content of more than 98.5 weight percent. According to the method, good cephalomannine removal effects are achieved, influence on the paclitaxel is eliminated, the purity and recovery rate of the paclitaxel are both higher, the method can be operated flexibly and conveniently, and is suitable for industrial production, reaction and treatment conditions are mild, and the difficulty of refining steps is lowered.

Description

technical field [0001] The invention relates to the technical field of separation and purification of paclitaxel, in particular to a method for removing cephalomannine in paclitaxel. Background technique [0002] Paclitaxel is the most promising anticancer drug discovered in the world in the past two decades. It was first isolated from the bark of Taxus brevifolia in 1967 and has been approved by the US FDA for ovarian cancer, breast cancer and non-small cell lung cancer. Waiting for treatment. [0003] Paclitaxel belongs to diterpene alkaloids, and its content in Taxus plants is very low, only 0.0004% to 0.01% (w / w). Such a low content makes it very difficult to extract and purify paclitaxel from raw materials to achieve pure products. difficulty. Natural yew resources are extremely limited, and yew grows slowly, which cannot meet the needs of paclitaxel production. Therefore, the method for purifying paclitaxel is particularly important. [0004] Cephalomannine is a na...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D305/14
CPCC07D305/14
Inventor 胡立丁正飞任莉喻琼林
Owner 无锡紫杉药业股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products